- - Human and in vivo Studies Indicate Lantus(R) Metabolites do not ...
- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today, at the 71st Scientific ...
- - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...
- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today ...